These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20411822)

  • 1. [Alzheimer's disease].
    Jedidi H; Jedidi Z; Salmon E
    Rev Med Liege; 2010 Mar; 65(3):163-8. PubMed ID: 20411822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metrifonate for Alzheimer's disease patients.
    Schneider LS
    J Clin Psychiatry; 2000 Mar; 61(3):218-9. PubMed ID: 10817111
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort.
    Behl P; Lanctôt KL; Streiner DL; Black SE
    Int Psychogeriatr; 2008 Dec; 20(6):1141-59. PubMed ID: 18606043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of Alzheimer's disease.
    Grossberg GT
    J Clin Psychiatry; 2003; 64 Suppl 9():3-6. PubMed ID: 12934967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.
    Zubenko GS; Zubenko WN; McPherson S; Spoor E; Marin DB; Farlow MR; Smith GE; Geda YE; Cummings JL; Petersen RC; Sunderland T
    Am J Psychiatry; 2003 May; 160(5):857-66. PubMed ID: 12727688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions and diagnostics in Alzheimer's disease and related conditions.
    Lippa CF
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):107-8. PubMed ID: 20229623
    [No Abstract]   [Full Text] [Related]  

  • 8. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
    Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL
    Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: early diagnosis and treatment.
    Chu LW
    Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
    Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
    Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating patients and caregivers through the course of Alzheimer's disease.
    Aupperle PM
    J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K; Fay S; Gorman M
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinesterase inhibitors and Alzheimer's disease outcomes.
    Garcia A; Thompson K; Zanibbi K; Geick S; Adams R
    J Gerontol A Biol Sci Med Sci; 2007 May; 62(5):570. PubMed ID: 17522364
    [No Abstract]   [Full Text] [Related]  

  • 15. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
    Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 17. Early diagnosis and management of Alzheimer's disease.
    Duncan BA; Siegal AP
    J Clin Psychiatry; 1998; 59 Suppl 9():15-21. PubMed ID: 9720482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
    Senin U; Cherubini A; Palumbo B; Mecocci P
    Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.